BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wadee AA, Paterson A, Coplan KA, Reddy SG. HLA expression in hepatocellular carcinoma cell lines. Clin Exp Immunol 1994;97:328-33. [PMID: 8050184 DOI: 10.1111/j.1365-2249.1994.tb06089.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Singal DP, Ye M, Ni J, Snider DP. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines. Immunology Letters 1996;50:149-54. [DOI: 10.1016/0165-2478(96)02531-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
2 Mullen CA. Review: Analogies Between Trophoblastic and Malignant Cells. American Journal of Reproductive Immunology 1998;39:41-9. [DOI: 10.1111/j.1600-0897.1998.tb00332.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
3 Sontini V, Gozzini A, Scappini B, Grossi A, Ferrini PR. Searching for the Magic Bullet Against Cancer: The Butyrate Saga. Leukemia & Lymphoma 2009;42:275-89. [DOI: 10.3109/10428190109064584] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
4 Garrido F. MHC/HLA Class I Loss in Cancer Cells. Adv Exp Med Biol 2019;1151:15-78. [PMID: 31140106 DOI: 10.1007/978-3-030-17864-2_2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
5 Wadee AA, Kuschke RH, Dooms TG. The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants. Clin Exp Immunol 1995;100:434-9. [PMID: 7774052 DOI: 10.1111/j.1365-2249.1995.tb03718.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
6 Balhorn R, Balhorn MC. Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers. Oncotarget 2020;11:3315-49. [PMID: 32934776 DOI: 10.18632/oncotarget.27709] [Reference Citation Analysis]
7 Pouillart PR. Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies. Life Sci. 1998;63:1739-1760. [PMID: 9820119 DOI: 10.1016/s0024-3205(98)00279-3] [Cited by in Crossref: 72] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
8 Lin Y, Liu C, Lei H, Yeh T, Lin Y, Chen RM, Liu H. Infection of five human liver cell lines by dengue-2 virus. J Med Virol 2000;60:425-31. [DOI: 10.1002/(sici)1096-9071(200004)60:4<425::aid-jmv10>3.0.co;2-a] [Cited by in Crossref: 62] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
9 Huang J, Cai MY, Wei DP. HLA class I expression in primary hepatocellular carcinoma. World J Gastroenterol 2002; 8(4): 654-657 [PMID: 12174373 DOI: 10.3748/wjg.v8.i4.654] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
10 Tsuchiya N, Sawada Y, Endo I, Uemura Y, Nakatsura T. Potentiality of immunotherapy against hepatocellular carcinoma. World J Gastroenterol 2015; 21(36): 10314-10326 [PMID: 26420958 DOI: 10.3748/wjg.v21.i36.10314] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
11 Lei WY, Hsiung SC, Wen SH, Hsieh CH, Chen CL, Wallace CG, Chang CC, Liao SK. Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines. J Immunol Res 2018;2018:8363265. [PMID: 30648121 DOI: 10.1155/2018/8363265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Fujiwara K, Higashi T, Nouso K, Nakatsukasa H, Kobayashi Y, Uemura M, Nakamura S, Sato S, Hanafusa T, Yumoto Y, Naito I, Shiratori Y. Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2004;19:1121-1127. [PMID: 15377288 DOI: 10.1111/j.1440-1746.2004.03467.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
13 Matoba K, Iizuka N, Gondo T, Ishihara T, Yamada-Okabe H, Tamesa T, Takemoto N, Hashimoto K, Sakamoto K, Miyamoto T. Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma. Int J Cancer. 2005;115:231-240. [PMID: 15688398 DOI: 10.1002/ijc.20860] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
14 Gao DY, Ling Y, Lou XL, Wang YY, Liu LM. GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer. Oncol Lett 2018;15:3133-40. [PMID: 29435047 DOI: 10.3892/ol.2017.7695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Singal DP, Ye M, Qiu X. Molecular basis for lack of expression of HLA class I antigens in human small-cell lung carcinoma cell lines. Int J Cancer 1996;68:629-36. [DOI: 10.1002/(sici)1097-0215(19961127)68:5<629::aid-ijc13>3.0.co;2-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
16 Chen W, Cai MY, Wei DP, Wang X. Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma. World J Gastroenterol 2005; 11(21): 3297-3299 [PMID: 15929187 DOI: 10.3748/wjg.v11.i21.3297] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
17 Chiu JH, Ju CH, Wu LH, Lui WY, Wu CW, Shiao MS, Hong CY. Cordyceps sinensis increases the expression of major histocompatibility complex class II antigens on human hepatoma cell line HA22T/VGH cells. Am J Chin Med. 1998;26:159-170. [PMID: 9799968 DOI: 10.1142/s0192415x9800021x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]